<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01355185</url>
  </required_header>
  <id_info>
    <org_study_id>25750</org_study_id>
    <nct_id>NCT01355185</nct_id>
  </id_info>
  <brief_title>Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences</brief_title>
  <official_title>Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AHS Cancer Control Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Association of Radiation Oncology</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AHS Cancer Control Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are substantial uncertainties with contemporary seed placement techniques in prostate
      brachytherapy, particularly with the impact of seed movement after an implant due to edema
      and migration of seeds in the prostate and peri-prostatic tissues. This study will accrue 20
      patients undergoing prostate brachytherapy implants and perform serial CT and MRI scans at
      specified intervals (pre-operatively, day 0, day 3, day 10 and day 28) to characterize these
      phenomena.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prostate brachytherapy is an effective treatment option for men with localized prostate
      cancer with excellent cure rates and a favorable toxicity profile. Having a more detailed
      understanding of seed movement after an implant will provide clinicians with details about
      the clinical impact of these phenomena on implants and provide the detailed understanding of
      these phenomena that are necessary for more sophisticated brachytherapy implants that are
      envisioned in the future.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Prostate Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients seen at an academic institution (tertiary centre ...Cross Cancer Institute) for
        consideration of prostate brachytherapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  treated with prostate brachytherapy

          -  low risk or intermediate risk prostate cancer

          -  ambulatory

          -  stable medical condition

          -  18 years of age or older

          -  capable of informed consent

        Exclusion Criteria:

          -  no use of any hormonal therapy

          -  unable to have MRI scans (ie. presence of metallic foreign object, aneurysm clip,
             cardiac pacemaker, internal wires, implanted pump, implanted cardiac device,
             claustrophobia, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nawaid Usmani, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ronald Sloboda, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nawaid Usmani, MD, FRCPC</last_name>
    <phone>780-432-8518</phone>
    <email>Nawaid.Usmani@albertahealthservices.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ronald Sloboda, PhD</last_name>
    <phone>780-432-8719</phone>
    <email>Ron.Sloboda@albertahealthservices.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cross Cancer Institute</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nawaid Usmani, MD, FRCPC</last_name>
      <phone>780-432-8518</phone>
      <email>Nawaid.Usmani@albertahealthservices.ca</email>
    </contact>
    <contact_backup>
      <last_name>Ron Sloboda, PHD</last_name>
      <phone>780-432-8719</phone>
      <email>Ron.Sloboda@albertahealthservices.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Nawaid Usmani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Sloboda RS, Usmani N, Pedersen J, Murtha A, Pervez N, Yee D. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging. Brachytherapy. 2010 Oct-Dec;9(4):354-61. doi: 10.1016/j.brachy.2009.09.008. Epub 2010 Jan 29.</citation>
    <PMID>20116344</PMID>
  </reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2011</study_first_submitted>
  <study_first_submitted_qc>May 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2011</study_first_posted>
  <last_update_submitted>October 1, 2014</last_update_submitted>
  <last_update_submitted_qc>October 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Seed movement</keyword>
  <keyword>implants</keyword>
  <keyword>prostate brachytherapy</keyword>
  <keyword>localized</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

